Key Takeaways:
- KIZOO Technology Capital is a German-based startup that provides mentoring, seed and early-stage financing with special focus on rejuvenation biotech.
- Operates under the Forever Healthy Group to create startups aimed at turning research on aging root causes into human therapies and services.
- Founded by veteran entrepreneurs, Frank Schueler, Matthias Hornberger, and Michael Greve, the team brings their knowledge and success from both tech and biotech companies.
- Actively supports initiatives such as new rejuvenation therapies, funding research projects on aging causes, and hosting the annual Undoing Aging Conference.
- Rejuvenation biotech is predicted to outgrow today’s largest technology markets in the foreseeable future.
As the world gears towards attaining longevity and maintaining youthfulness, one startup that is at the forefront of this revolution is named KIZOO Technology Capital. Based in Karlsruhe, Germany, KIZOO’s mission is clear and focused: providing mentoring, seed and early-stage financing with a special focus on rejuvenation biotech. By directing their resources towards the emerging field of rejuvenation biotech, KIZOO is positioning itself as a leader in an industry that is predicted to surpass today’s largest technology markets.
KIZOO operates under the umbrella of the Forever Healthy Group, a consortium that is involved in creating startups tailored towards turning research on aging root causes into services and therapies for humans. Through this initiative, they are not only offering an innovative solution to combating age-related diseases, but they are also creating a space where breakthroughs in understanding the underlying causes of aging are created and nurtured.
In differentiating KIZOO Technology Capital, it is essential to note the depth of experience its founders bring. Having been entrepreneurs, VCs and mentors in both high growth tech and biotech companies, founders Frank Schueler, Matthias Hornberger, and Michael Greve bring their knowledge and success to the young industry of rejuvenation biotech. They leverage their wealth of experience to mentor, guide, and fund early-stage startups in this burgeoning industry.
Moreover, KIZOO’s commitment to the emerging field of rejuvenation biotech extends beyond the financing and mentoring of startups. They actively support various initiatives dedicated to this field, including evaluation of new rejuvenation therapies, evidenced-based curation of cutting-edge global medical knowledge, funding research projects focusing on the root causes of aging, and hosting the annual Undoing Aging Conference.
In conclusion, the rejuvenation biotech industry holds significant promise for the future, and KIZOO Technology Capital is poised to capitalize on this prospective golden age of anti-aging. If the successes of the tech and biotech industries are anything to go by, then KIZOO – with its vast wealth of experience, strategic focus, and forward-thinking initiatives – is set to play a leading role in the emergence and growth of the rejuvenation biotech industry.
To get involved or learn more about KIZOO’s work, visit their website at www.kizoo.com. Stay connected via their social media platforms: Twitter, Facebook, and LinkedIn.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
